Adrian Harel/LinkedIn
Jun 17, 2026, 16:29
Adrian Harel: Medicortex’s Review on Diagnostic Biomarkers of Ischemic Stroke Is Live Now
Adrian Harel, Founder and CEO at Medicortex Finland Oyj, shared on LinkedIn about a recent article he and his colleagues co-authored, published in Frontiers, adding:
”Medicortex’s review article on diagnostic biomarkers of ischemic stroke was just published.”
Title: Diagnostic biomarkers of ischemic stroke: strengths and limitations across blood, urine, and saliva
Authors: Begüm Utz, Pihla Miettinen, Ivette Bañuelos-Cabrera, Leonardo Lara-Valderrábano, Lasse Välimaa, Adrian Harel
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 17, 2026, 16:43Aleksandra Pikula: Canada’s First Women in Midlife Brain Health and Stroke Prevention Program Is Officially Launched
-
Jun 17, 2026, 16:42Alejandro González Veliz: Not Every Acs Patient Needs 12 Months of Dapt
-
Jun 17, 2026, 16:23Dima Shulkin: Can a Computer Learn to Read Blood the Way a Doctor Does?
-
Jun 17, 2026, 16:11Extremely Rare Bleeding Disorder of the Month – Bernard–Soulier Syndrome – EHC
-
Jun 17, 2026, 16:11Raquel Enciso Serradilla: The Nutritional Gaps Behind Millions of Heart Attacks and Strokes
-
Jun 17, 2026, 16:04Waqas Mehmood: Exploring Disseminated Intravascular Coagulation
-
Jun 17, 2026, 15:35Alexis Guédon: Cancer-Associated Upper-Extremity Deep Vein Thrombosis
-
Jun 17, 2026, 15:28Gaurav Wagh: Hemophilia Gene Therapy Market – Request a Sample Report
-
Jun 17, 2026, 15:14Sonal Sonu: Who Are the Donors We Need the Most?